Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Can inhaled insulin improve glycemic control of type 2 diabetes?

Nature Clinical Practice Endocrinology & Metabolism volume 2, pages 308–309 (2006)Cite this article

boxed-textRosenstock J et al. (2005) Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes. Ann Intern Med 143: 549–558

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Becker R et al. (2006) The effect of smoking cessation and subsequent resumption on absorption of inhaled insulin. Diabetes Care 29: 277−282

    Article  Google Scholar 

  2. Riddle MC et al. (2003) The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 26: 3080–3086

    Article  CAS  Google Scholar 

  3. Peyrot M et al. (2005) Resistance to insulin therapy among patients and providers: results of the cross-national diabetes attitudes, wishes, and needs (DAWN) study. Diabetes Care 28: 2673–2679

    Article  Google Scholar 

  4. Grant JB et al. (2005) Quality of diabetes care in US academic medical centers: low rates of medical regimen change. Diabetes Care 28: 337–442

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice. Dr J Christopher Lynch, of Southern Illinois University, IL, USA, provided helpful comments about the commentary.

Author information

Authors and Affiliations

  1. Harvard Medical School,

    Merri Pendergrass

  2. Diabetes Section at Brigham and Women's Hospital, Boston, MA, USA

    Merri Pendergrass

Authors
  1. Merri Pendergrass
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Merri Pendergrass.

Ethics declarations

Competing interests

Dr Pendergrass has received research funding from Novo Nordisk.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pendergrass, M. Can inhaled insulin improve glycemic control of type 2 diabetes?. Nat Rev Endocrinol 2, 308–309 (2006). https://doi.org/10.1038/ncpendmet0168

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0168

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing